Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$11.83 USD
-0.05 (-0.42%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $11.48 -0.35 (-2.96%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AVTX 11.83 -0.05(-0.42%)
Will AVTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AVTX
Is AVTX preparing to trend higher? MACD Bullish Signal Line Cross shows up after slipping 0.42%
AVTX forms Pocket Pivot on September 19
Crossed Above 20 Day Moving Average appears for AVTX after 16.09% move
Oppenheimer Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX)
AVTX: HC Wainwright & Co. Raises Price Target and Maintains Buy Rating | AVTX Stock News